Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings.
about
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findingsHub and switches: endocannabinoid signalling in midbrain dopamine neuronsRole of cues and contexts on drug-seeking behaviourThe Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys.Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionNicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.Stimulation of nicotine reward and central cholinergic activity in Sprague-Dawley rats exposed perinatally to a fat-rich diet.PPAR agonists regulate brain gene expression: relationship to their effects on ethanol consumptionPrior exposure to THC increases the addictive effects of nicotine in rats.The Reinforcing Effects of Nicotine in Humans and Nonhuman Primates: A Review of Intravenous Self-Administration Evidence and Future Directions for Research.Neuroimmune pathways in alcohol consumption: evidence from behavioral and genetic studies in rodents and humansAnti-kindling Effect of Bezafibrate, a Peroxisome Proliferator-activated Receptors Alpha Agonist, in Pentylenetetrazole Induced Kindling Seizure Model.Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humansEffects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and RelapseDifferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on nicotine versus cocaine self-administration and relapse in squirrel monkeys.Development of novel pharmacotherapeutics for tobacco dependence: progress and future directionsInitial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence.Peroxisome proliferator-activated receptor (PPAR) agonists as promising new medications for drug addiction: preclinical evidence.Effects of blockade of α4β2 and α7 nicotinic acetylcholine receptors on cue-induced reinstatement of nicotine-seeking behaviour in rats.Emerging targets for addiction neuropharmacology: From mechanisms to therapeuticsNeuroimmune signaling: a key component of alcohol abuse.Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives.Hepatic, lipid and genetic factors associated with obesity: crosstalk with alcohol dependence?Fenofibrate Administration Reduces Alcohol and Saccharin Intake in Rats: Possible Effects at Peripheral and Central LevelsIn vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.Initial Cross-Over Test of a Positive Allosteric Modulator of Alpha-7 Nicotinic Receptors to Aid Cessation in Smokers with or Without Schizophrenia.Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential.Lack of effects of simvastatin on smoking cessation in humans: A double-blind, randomized, placebo-controlled clinical study.The peroxisome proliferator-activated receptor alpha agonist fenofibrate attenuates alcohol self-administration in rats.Peroxisome Proliferator Activated Receptor Agonists Modulate Transposable Element Expression in Brain and LiverEmerging Therapeutic Role of PPAR-α in Cognition and EmotionsTesting the PPAR hypothesis of tobacco use disorder in humans: A randomized trial of the impact of gemfibrozil (a partial PPARα agonist) in smokers
P2860
Q21090748-97125ABD-49D7-40D5-AFC1-74F370738E0CQ24623244-BCBA277B-2795-42B3-8FB7-73ADE3CC3E2EQ26825476-71A7B2D5-02B5-485D-8D6C-59FA9AB5B08AQ27325802-3F5416CE-B9FA-41CC-9C67-E7623DE3BD97Q28283718-87506967-D77C-48BD-9072-AD8F0D791C9DQ30244252-5AF40FE0-9C7D-4FA2-8786-DAFCCCB8EDD0Q33552906-BA050B52-B4DF-4EAE-9263-0D9EC46FE953Q34302561-5EC621C1-F82F-4153-B6FD-E1C003B2F172Q34322263-DEB03FA7-0F6B-4D1E-8473-FE0CA820A6EFQ34462263-918FC4E5-FB3D-4AA9-8329-C08F41B20C49Q34687635-12B2DFFC-6D93-4C83-8BC6-DCCE993145D2Q34965339-46B93D91-621C-48D5-9BAD-EF63CA9324D5Q35019725-C504C04E-BDC1-40F3-ADD5-2CDF7B9DC199Q36184904-A4ED4824-E246-44A3-A8D9-D6C117E7982AQ36445709-8610CF37-17C8-42C4-B19C-A9721D174A8EQ36727844-787C4FD6-76B0-4E03-8A1C-8598EE0E3A9CQ36939862-A5B2C543-2CEE-45A4-833B-2777400D74ABQ37304747-1A084B89-02A4-403A-9F67-2CAF21B4633FQ37351302-1F75A091-0215-499C-95A2-134C97123513Q37397620-B5C868DE-C4D4-4E0B-80C4-1C5DFB068076Q38083975-DFF1D91B-D590-41ED-BBFF-08BE1B291430Q38686274-0679B236-6EC6-4483-B353-86B26BFD3719Q38788717-CF4CF219-A742-4DC7-B77C-C5E9F13BA239Q41010706-4AAA767D-C885-4D84-A879-E86FA8EE9EBAQ45054305-BBF6A0FD-A3FC-416D-AB13-D0B658436C08Q45074229-1B5ECC2D-177D-45AB-B0EA-8D0C8DC9FE49Q50094674-FD1CE455-FCAA-4F5A-AB4C-8494DFB17AD6Q51745545-ED9811D8-54F2-45FB-8C15-3ED5C8B25973Q52311615-0A984D0B-DD22-4143-A7FB-7E72097DCDA8Q57072853-B260F8F1-E06C-4B36-902C-D052BB144476Q57818280-3A1BC294-9E28-4DC6-B608-BB96A8A68BC7Q58691808-4231E943-9A32-44AD-8204-2D903770A361
P2860
Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Novel use of a lipid-lowering ...... relapse: preclinical findings.
@ast
Novel use of a lipid-lowering ...... relapse: preclinical findings.
@en
type
label
Novel use of a lipid-lowering ...... relapse: preclinical findings.
@ast
Novel use of a lipid-lowering ...... relapse: preclinical findings.
@en
prefLabel
Novel use of a lipid-lowering ...... relapse: preclinical findings.
@ast
Novel use of a lipid-lowering ...... relapse: preclinical findings.
@en
P2093
P2860
P50
P356
P1476
Novel use of a lipid-lowering ...... relapse: preclinical findings
@en
P2093
Chanel Barnes
Godfrey H Redhi
Jordan Adair
Leigh V Panlilio
Mano Aliczki
Marco Pistis
Paola Mascia
Salvatore Lecca
Sevil Yasar
Stephen J Heishman
P2860
P2888
P304
P356
10.1038/NPP.2012.31
P407
P577
2012-03-28T00:00:00Z